Effects of scopolamine on dopamine neurons in the substantia nigra: Role of the pedunculopontine tegmental nucleus

Synapse

Volumn 63, Issue 8, 2009, Pages 673-680

  Di Giovanni, Giuseppe ^a,b   Shi, Wei Xing ^b,c  

^a UNIVERSITY OF PALERMO   (Italy)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOMA LINDA UNIVERSITY   (United States)

Author keywords

Acetylcholine; Basal ganglia; Cells per track; Dopamine; Microiontophoresis; Parkinson's disease; Scopolamine; Single unit recording; Striatum; Substantia nigra pars compacta

Indexed keywords

ACETYLCHOLINE; AUTORECEPTOR; DOPAMINE; MUSCARINIC RECEPTOR; SCOPOLAMINE;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DRUG EFFECT; DRUG INFUSION; MALE; MICROIONTOPHORESIS; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SUBSTANTIA NIGRA;

ACETYLCHOLINE; ACTION POTENTIALS; ANALYSIS OF VARIANCE; ANIMALS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; IONTOPHORESIS; MALE; MUSCARINIC ANTAGONISTS; NEURONS; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; RATS; RATS, SPRAGUE-DAWLEY; SCOPOLAMINE; SUBSTANTIA NIGRA;

EID: 67650418166     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20650     Document Type: Article

References (79)

1. Alderson HL, Winn P. 2005. The pedunculopontine and reinforcement. In: Bolam JP, Ingham CA, Magill PJ, editors. The basal ganglia. VIII. Advances in behavioral biology, Vol. 56. Springer. p 523-532.
2. Beninato M, Spencer RFA. 1987. Cholinergic projection to the rat substantia nigra from the pedunculopontine tegmental nucleus. Brain Res 412:169-174.
3. Bolden C, Cusack B, Richelson E. 1992. Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells. J Pharmacol Exp Ther 260:576-580.
4. Bosboom JL, Stoffers D, Wolters ECh. 2003. The role of acetylcholine and dopamine in dementia and psychosis in Parkinson's disease. J Neural Transm Suppl 65:185-195.
5. Breit S, Lessmann L, Benazzouz A, Schulz JB. 2005. Unilateral lesion of the pedunculopontine nucleus induces hyperactivity in the subthalamic nucleus and substantia nigra in the rat. Eur J Neurosci 22:2283-2294.
6. Bunney BS, Grace AA. 1978. Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity. Life Sci 23:1715-1728.
7. Bunney BS, Walters JR, Roth RH, Aghajanian GK. 1973. Dopaminergic neurons: Effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther 185:560-571.
8. Bunney BS, Chiodo LA, Grace AA. 1991. Midbrain dopamine system electrophysiological functioning: A review and new hypothesis. Synapse 9:79-94.
9. Calabresi P, Lacey MG, North RA. 1989. Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording. Br J Pharmacol 98:135-140.
10. Chapman CA, Yeomans JS, Blaha CD, Blackburn JR. 1997. Increased striatal dopamine efflux follows scopolamine administered systemically or to the tegmental pedunculopontine nucleus. Neuroscience 76:177-186.
11. Chen J, Nakamura M, Kawamura T, Takahashi T, Nakahara D. 2006. Roles of pedunculopontine tegmental cholinergic receptors in brain stimulation reward in the rat. Psychopharmacology (Berl) 184:514-522.
12. Chiodo LA, Bunney BS. 1985. Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons. J Neurosci 5:2539-2544.
13. Cragg SJ. 2006. Meaningful silences: How dopamine listens to the ACh pause. Trends Neurosci 29:125-131.
14. Floresco SB, Todd CL, Grace AA. 2001. Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons. J Neurosci 21:4915-4922.
15. Floresco SB, West AR, Ash B, Moore H, Grace AA. 2003. Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat Neurosci 6:968-973.
16. Forster GL, Blaha CD. 2003. Pedunculopontine tegmental stimulation evokes striatal dopamine efflux by activation of acetylcholine and glutamate receptors in the midbrain and pons of the rat. Eur J Neurosci 17:751-762.
17. Fuller PM, Saper CB, Lu J. 2007. The pontine REM switch: Past and present. J Physiol 584:735-741.
18. Futami T, Takakusaki K, Kitai ST. 1995. Glutamatergic and cholinergic inputs from the pedunculopontine tegmental nucleus to dopamine neurons in the substantia nigra pars compacta. Neurosci Res 21:331-342.
19. Glick SD, Guido RA. 1982. Scopolamine self-administration: Cholinergic involvement in reward mechanisms. Life Sci 31:909-913.
20. Grace AA. 1991. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia. Neuroscience 41:1-24.
21. Grace AA, Bunney BS. 1980. Nigral dopamine neurons: Intracellular recording and identification with L-dopa injection and histo-fluorescence. Science 210:654-656.
22. Grace AA, Bunney BS. 1983. Intracellular and extracellular electrophysiology of nigral dopaminergic neurons. I. Identification and characterization. Neuroscience 10:301-315.
23. Grace AA, Bunney BS. 1986. Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: Analysis using in vivo intracellular recording. J Pharmacol Exp Ther 238:1092-1100.
24. Grace AA, Floresco SB, Goto Y, Lodge DJ. 2007. Regulation of firing of dopaminergic neurons and control of goal-directed behaviours. Trends Neurosci 30:220-227.
25. Grelak RP, Clark R, Stump JM, Vernier VG. 1970. Amantadine-dopamine interaction: Possible mode of action in Parkinsonism. Science 169:203-204.
26. Grenhoff J, Janson AM, Svensson TH, Fuxe K. 1991. Chronic continuous nicotine treatment causes decreased burst firing of nigral dopamine neurons in rats partially hemitransected at the mesodiencephalic junction. Brain Res 562:347-351.
27. Grofova I, Zhou M. 1998. Nigral innervation of cholinergic and glutamatergic cells in the rat mesopontine tegmentum: Light and electron microscopic anterograde tracing and immunohistochemical studies. J Comp Neurol 395:359-379.
28. Gronier B, Rasmussen K. 1998. Activation of midbrain presumed dopaminergic neurones by muscarinic cholinergic receptors: An in vivo electrophysiological study in the rat. Br J Pharmacol 124:455-464.
29. Hand TH, Hu XT, Wang RY. 1987. Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons. Brain Res 415:257-269.
30. Henderson Z, Greenfield SA. 1987. Does the substantia nigra have a cholinergic innervation? Neurosci Lett 73:109-113.
31. Henderson Z, Sherriff FE. 1991. Distribution of choline acetyltransferase immunoreactive axons and terminals in the rat and ferret brainstem. J Comp Neurol 314:147-163.
32. Hoebel BG, Avena NM, Rada P. 2007. Accumbens dopamine-acetylcholine balance in approach and avoidance. Curr Opin Pharmacol 7:617-627.
33. Ichinohe N, Teng B, Kitai ST. 2000. Morphological study of the tegmental pedunculopontine nucleus, substantia nigra and subthalamic nucleus, and their interconnections in rat organotypic culture. Anat Embryol (Berl) 201:435-453.
34. Kelland MD, Freeman AS, Rubin J, Chiodo LA. 1993. Ascending afferent regulation of rat midbrain dopamine neurons. Brain Res Bull 31:539-546.
35. Kitai ST, Shepard PD, Callaway JC, Scroggs R. 1999. Afferent modulation of dopamine neuron firing patterns. Curr Opin Neurobiol 9:690-697.
36. Lacey MG, Calabresi P, North RA. 1990. Muscarine depolarizes rat substantia nigra zona compacta and ventral tegmental neurons in vitro through M1-like receptors. J Pharmacol Exp Ther 253:395-400.
37. Lees A. 2005. Alternatives to levodopa in the initial treatment of early Parkinson's disease. Drugs Aging 22:731-740.
38. Liu Y, Dore J, Chen X. 2007. Calcium influx through L-type channels generates protein kinase M to induce burst firing of dopamine cells in the rat ventral tegmental area. J Biol Chem 282:8594-8603.
39. Lodge DJ, Grace AA. 2006a. The laterodorsal tegmentum is essential for burst firing of ventral tegmental area dopamine neurons. Proc Natl Acad Sci USA 103:5167-5172.
40. Lodge DJ, Grace AA. 2006b. The hippocampus modulates dopamine neuron responsivity by regulating the intensity of phasic neuron activation. Neuropsychopharmacology 31:1356-1361.
41. Lodge DJ, Grace AA. 2008. Amphetamine activation of hippocampal drive of mesolimbic dopamine neurons: A mechanism of behavioral sensitization. J Neurosci 28:7876-7882.
42. Lokwan SJ, Overton PG, Berry MS, Clark D. 1999. Stimulation of the pedunculopontine tegmental nucleus in the rat produces burst firing in A9 dopaminergic neurons. Neuroscience 92:245-254.
43. Maskos U. 2007. Emerging concepts: Novel integration of in vivo approaches to localize the function of nicotinic receptors. J Neurochem 100:596-602.
44. Maskos U. 2008. The cholinergic mesopontine tegmentum is a relatively neglected nicotinic master modulator of the dopaminergic system: Relevance to drugs of abuse and pathology. Br J Pharmacol 153 (Suppl 1):S438-S445.
45. Mathur A, Shandarin A, LaViolette SR, Parker J, Yeomans JS. 1997. Locomotion and stereotypy induced by scopolamine: Contributions of muscarinic receptors near the pedunculopontine tegmental nucleus. Brain Res 775:144-155.
46. Mena-Segovia J, Winn P, Bolam JP. 2008. Cholinergic modulation of midbrain dopaminergic systems. Brain Res 58:265-271.
47. Miller AD, Blaha CD. 2004. Nigrostriatal dopamine release modulated by mesopontine muscarinic receptors. Neuroreport 15:1805-1808.
48. Miller AD, Blaha CD. 2005. Midbrain muscarinic receptor mechanisms underlying regulation of mesoaccumbens and nigrostriatal dopaminergic transmission in the rat. Eur J Neurosci 21:1837-1846.
49. Moore H, Todd CL, Grace AA. 1998. Striatal extracellular dopamine levels in rats with haloperidol-induced depolarization block of substantia nigra dopamine neurons. J Neurosci 18:5068-5077.
50. Oakman SA, Faris PL, Kerr PE, Cozzari C, Hartman BK. 1995. Distribution of pontomesencephalic cholinergic neurons projecting to substantia nigra differs significantly from those projecting to ventral tegmental area. J Neurosci 15:5859-5869.
51. Oakman SA, Faris PL, Cozzari C, Hartman BK. 1999. Characterization of the extent of pontomesencephalic cholinergic neurons' projections to the thalamus: Comparison with projections to midbrain dopaminergic groups. Neuroscience 94:529-547.
52. Pan WX, Hyland BI. 2005. Pedunculopontine tegmental nucleus controls conditioned responses of midbrain dopamine neurons in behaving rats. J Neurosci 25:4725-4732.
53. Paxinos G, Watson C. 1997. The rat brain in stereotaxic coordinates, 3rd ed. New York: Academic Press.
54. Pucak ML, Grace AA. 1991. Partial dopamine depletions result in an enhanced sensitivity of residual dopamine neurons to apomorphine. Synapse 9:144-155.
55. Rasmussen T, Fink-Jensen A. 2000. Intravenous scopolamine is potently self-administered in drug-naive mice. Neuropsychopharmacology 22:97-99.
56. Sarter M, Bruno JP, Parikh V, Martinez V, Kozak R, Richards JB. 2006. Forebrain dopaminergic-cholinergic interactions, attentional effort, psychostimulant addiction and schizophrenia. EXS 98:65-86.
57. Scarnati E, Campana E, Pacitti C. 1984. Pedunculopontine-evoked excitation of substantia nigra neurons in the rat. Brain Res 304:351-361.
58. Scarnati E, Proia E, Campana E, Pacitti C. 1986. A microiontophoretic study on the nature of the putative neurotransmitter involved in the pedunculopontine-substantia nigra pars compacta excitatory pathway in the rat. Exp Brain Res 62:470-478.
59. Scarnati E, Proia A, Di Loreto S, Pacitti C. 1987. The reciprocal electrophysiological influence between the nucleus tegmenti pedunculopontinus and the substantia nigra in normal and decorticated rats. Brain Res 423:116-124.
60. Schmitz Y, Benoit-Marand M, Gonon F, Sulzer D. 2003. Presynaptic regulation of dopaminergic neurotransmission. J Neurochem 87:273-289.
61. Scroggs RS, Cardenas CG, Whittaker JA, Kitai ST. 2001. Muscarine reduces calcium-dependent electrical activity in substantia nigra dopaminergic neurons. J Neurophysiol 86:2966-2972.
62. Semba K, Fibiger HC. 1992. Afferent connections of the laterodorsal and the pedunculopontine tegmental nuclei in the rat: A retro-and antero-grade transport and immunohistochemical study. J Comp Neurol 323:387-410.
63. Shim SS, Bunney BS, Shi WX. 1996. Effects of lesions in the medial prefrontal cortex on the activity of midbrain dopamine neurons. Neuropsychopharmacology 15:437-441.
64. Skirboll LR, Grace AA, Hommer DW, Rehfeld J, Goldstein M, Hökfelt T, Bunney BS. 1981. Peptide-monoamine coexistence: Studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons. Neuroscience 6:2111-2124.
65. Smith ID, Grace AA. 1992. Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity. Synapse 12:287-303.
66. Sorenson EM, Shiroyama T, Kitai ST. 1998. Postsynaptic nicotinic receptors on dopaminergic neurons in the substantia nigra pars compacta of the rat. Neuroscience 87:659-673.
67. Steiniger B, Kretschmer BD. 2003. Glutamate and GABA modulate dopamine in the pedunculopontine tegmental nucleus. Exp Brain Res 149:422-430.
68. Steininger TL, Rye DB, Wainer BH. 1992. Afferent projections to the cholinergic pedunculopontine tegmental nucleus and adjacent midbrain extrapyramidal area in the albino rat. I. Retrograde tracing studies. J Comp Neurol 321:515-543.
69. Todd CL, Grace AA. 1999. Interaction of benztropine and haloperidol actions on rat substantia nigra dopamine cell electrophysiological activity in vivo. Brain Res Bull 48:219-222.
70. Tokuno H, Moriizumi T, Kudo M, Nakamura Y. 1988. A morphological evidence for monosynaptic projections for the nucleus tegmenti pedunculopontinus pars compacta (TPC) to nigrostriatal projection neurons. Neurosci Lett 85:1-4.
71. Tzavara ET, Bymaster FP, Davis RJ, Wade MR, Perry KW, Wess J, McKinzie DL, Felder C, Nomikos GG. 2004. M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: Relevance to the pathophysiology and treatment of related CNS pathologies. FASEB J 18:1410-1412.
72. Volkmann J. 2007. Update on surgery for Parkinson's disease. Curr Opin Neurol 20:465-469.
73. Williams MJ, Adinoff B. 2008. The role of acetylcholine in cocaine addiction. Neuropsychopharmacology 33:1779-1797.
74. Wisman LA, Sahin G, Maingay M, Leanza G, Kirik D. 2008. Functional convergence of dopaminergic and cholinergic input is critical for hippocampus-dependent working memory. J Neurosci 28:7797-7807.
75. Woodruff-Pak DS, Gould TJ. 2002. Neuronal nicotinic acetylcholine receptors: Involvement in Alzheimer's disease and schizophrenia. Behav Cogn Neurosci Rev 1:5-20.
76. Yeomans JS. 1995. Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia. Neuropsychopharmacology 12:3-16.
77. Zhang L, Liu Y, Chen X. 2005. Carbachol induces burst firing of dopamine cells in the ventral tegmental area by promoting calcium entry through L-type channels in the rat. J Physiol 568:469-481.
78. Zhang W, Yamada M, Gomeza J, Basile AS, Wess J. 2002. Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice. J Neurosci 22:6347-6352.
79. Zhou FM, Wilson C, Dani JA. 2003. Muscarinic and nicotinic cholinergic mechanisms in the mesostriatal dopamine systems. Neuroscientist 9:23-36.